Specifically, GLUT-1 was reported to correlate with the poor prognosis of diverse cancer types, such as colorectal cancer [21], while Arjen [10] and Elena [11] et al. demonstrated that GLUT-1 improved the outcomes of colorectal cancer patients (although their findings were inconsistent). The gene discussed is SLC2A1; the disease is colorectal cancer.